Supporting the Regulation of Medicines in Mongolia: Experiences, Lessons Learned, and Future Directions
Publication | May 2022
SHARE THIS PAGE
This paper describes the pharmaceutical sector in Mongolia and its reforms, including the results achieved, the challenges that remain, lessons learned, and future directions for ADB support.
Citable URL
Before the 1990s, Mongolia's pharmaceutical sector was fully owned and strictly regulated by the state. In the early 1990s, the Government of Mongolia started initial socioeconomic reforms as part of a transition to a market economy. This led to the full privatization and liberalization of the pharmaceutical sector, which created challenges that needed further reforms. The government requested ADB to support these reforms.
Contents
- The Pharmaceutical Sector in Mongolia
- ADB Support for Improving Regulation of Medicines in Mongolia
- Results Achieved with ADB Support in Improving Regulation of Medicines
- Challenges in Improving Regulation of Medicines
- Lessons Learned
- Future Directions
- Conclusions
Additional Details
| Authors | |
| Type | |
| Series | |
| Subjects |
|
| Countries |
|
| Pages |
|
| Dimensions |
|
| SKU |
|
Also in this Series
- Assessment of Natural Capital and Ecosystem Services: Two Cases of Ecosystem Restoration in the People’s Republic of China
- Human Settlements in Mongolia: Strengthening Strategic Cities and Towns for Sustainable Territorial Development
- Impact of Nontariff Measures and Border Crossing Time and Costs: The Case of Perishable Goods Trade in the Central Asia Regional Economic Cooperation Region